Generex Awarded New Patent in Europe
Company Expands Patent Portfolio in Several European Countries
"We are pleased that we have been granted this European patent," said Rose Perri, the Company's Chief Operating Officer as we plan ahead for our regulatory submissions with the centralized authorities in Europe.
Generex currently holds an aggregate of 142 patents worldwide (21 of which are United States patents) and has an aggregate of 120 patent applications pending in various jurisdictions.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.